SEC Investigation Targets David Banister and The Market Analysts Group
as harmed other BioVie investors who paid inflated prices for their shares and/or suffered trading losses after buying the stock following Defendants’ misleading recommendations.
The SEC is seeking a final judgment that would require the defendants to return all the ill-gotten gains they received from their actions during the Relevant Period, along with paying prejudgment interest. This is in accordance with Exchange Act Sections 21(d)(3), 21(d)(5), and 21(d)(7), as well as ordering the defendants to pay civil money penalties under Securities Act Section 20(d), Exchange Act Section 21(d)(3), and Advisers Act Section 209(e).
This lawsuit highlights the importance of transparency and honesty in financial dealings. It serves as a reminder that market manipulation and fraudulent schemes can have serious consequences for both investors and the individuals behind them. Investors should always be cautious and verify information provided to them before making any financial decisions.
As the case progresses, we will keep you updated on any developments. If you have any concerns about your investments or suspect any fraudulent activities, do not hesitate to reach out to the SEC or a financial advisor for guidance. Stay informed and make informed decisions to protect your investments and financial well-being.
